Characterization of naturally occurring protease inhibitor-resistance mutations in genotype 1b hepatitis C virus patients

被引:0
|
作者
Hiroko Shindo
Shinya Maekawa
Kazuki Komase
Ryota Sueki
Mika Miura
Makoto Kadokura
Kuniaki Shindo
Fumitake Amemiya
Takatoshi Kitamura
Yasuhiro Nakayama
Taisuke Inoue
Minoru Sakamoto
Shun-ichi Okada
Yasuhiro Asahina
Namiki Izumi
Masao Honda
Shuichi Kaneko
Nobuyuki Enomoto
机构
[1] University of Yamanashi,First Department of Internal Medicine
[2] Musashino Red Cross Hospital,Division of Gastroenterology and Hepatology
[3] Kanazawa University Graduate School of Medicine,Department of Gastroenterology
来源
Hepatology International | 2012年 / 6卷
关键词
HCV; Protease inhibitor; Naturally occurring viral resistance mutations;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:482 / 490
页数:8
相关论文
共 50 条
  • [1] Characterization of naturally occurring protease inhibitor-resistance mutations in genotype 1b hepatitis C virus patients
    Shindo, Hiroko
    Maekawa, Shinya
    Komase, Kazuki
    Sueki, Ryota
    Miura, Mika
    Kadokura, Makoto
    Shindo, Kuniaki
    Amemiya, Fumitake
    Kitamura, Takatoshi
    Nakayama, Yasuhiro
    Inoue, Taisuke
    Sakamoto, Minoru
    Okada, Shun-ichi
    Asahina, Yasuhiro
    Izumi, Namiki
    Honda, Masao
    Kaneko, Shuichi
    Enomoto, Nobuyuki
    HEPATOLOGY INTERNATIONAL, 2012, 6 (02) : 482 - 490
  • [2] Hepatitis C virus protease inhibitor-resistance mutations: Our experience and review
    Wu, Shuang
    Kanda, Tatsuo
    Nakamoto, Shingo
    Imazeki, Fumio
    Yokosuka, Osamu
    WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (47) : 8940 - 8948
  • [3] Hepatitis C virus protease inhibitor-resistance mutations: Our experience and review
    Shuang Wu
    Tatsuo Kanda
    Shingo Nakamoto
    Fumio Imazeki
    Osamu Yokosuka
    World Journal of Gastroenterology, 2013, 19 (47) : 8940 - 8948
  • [4] Prevalence of naturally occurring protease inhibitor resistance-associated variants in hemodialysis and renal transplant patients with hepatitis C virus infection
    Tavares, Rita C. F.
    Feldner, Ana C. C. A.
    Pinho, Joao R. R.
    Uehara, Silvia N. O.
    Emori, Christini T.
    Carvalho-Filho, Roberto J.
    Silva, Ivonete S. S.
    Santana, Rubia A. F.
    de Castro, Vanessa F. D.
    Castoli, Gregorio T. F.
    Cristovao, Charliana U.
    Ferraz, Maria L. C. G.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 29 (07) : 754 - 758
  • [5] Structural characterization of the Hepatitis C Virus NS3 protease from genotype 3a: The basis of the genotype 1b vs. 3a inhibitor potency shift
    Gallo, Mariana
    Bottomley, Matthew James
    Pennestri, Matteo
    Eliseo, Tommaso
    Paci, Maurizio
    Koch, Uwe
    Bazzo, Renzo
    Summa, Vincenzo
    Carfi, Andrea
    Cicero, Daniel O.
    VIROLOGY, 2010, 405 (02) : 424 - 438
  • [6] Prevalence of hepatitis C virus variants resistant to NS3 protease inhibitors or the NS5A inhibitor (BMS-790052) in hepatitis patients with genotype 1b
    Suzuki, Fumitaka
    Sezaki, Hitomi
    Akuta, Norio
    Suzuki, Yoshiyuki
    Seko, Yuya
    Kawamura, Yusuke
    Hosaka, Tetsuya
    Kobayashi, Masahiro
    Saito, Satoshi
    Arase, Yasuji
    Ikeda, Kenji
    Kobayashi, Mariko
    Mineta, Rie
    Watahiki, Sachiyo
    Miyakawa, Yuzo
    Kumada, Hiromitsu
    JOURNAL OF CLINICAL VIROLOGY, 2012, 54 (04) : 352 - 354
  • [7] Deep Sequencing and Phylogenetic Analysis of Variants Resistant to Interferon-Based Protease Inhibitor Therapy in Chronic Hepatitis Induced by Genotype 1b Hepatitis C Virus
    Sato, Mitsuaki
    Maekawa, Shinya
    Komatsu, Nobutoshi
    Tatsumi, Akihisa
    Miura, Mika
    Muraoka, Masaru
    Suzuki, Yuichiro
    Amemiya, Fumitake
    Takano, Shinichi
    Fukasawa, Mitsuharu
    Nakayama, Yasuhiro
    Yamaguchi, Tatsuya
    Uetake, Tomoyoshi
    Inoue, Taisuke
    Sato, Tadashi
    Sakamoto, Minoru
    Yamashita, Atsuya
    Moriishi, Kohji
    Enomotoa, Nobuyuki
    JOURNAL OF VIROLOGY, 2015, 89 (11) : 6105 - 6116
  • [8] Analysis of Hepatitis C Virus Genotype 1b Resistance Variants in Japanese Patients Treated with Paritaprevir-Ritonavir and Ombitasvir
    Krishnan, Preethi
    Schnell, Gretja
    Tripathi, Rakesh
    Beyer, Jill
    Reisch, Thomas
    Zhang, Xinyan
    Setze, Carolyn
    Rodrigues, Lino, Jr.
    Burroughs, Margaret
    Redman, Rebecca
    Chayama, Kazuaki
    Kumada, Hiromitsu
    Collins, Christine
    Pilot-Matias, Tami
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (02) : 1106 - 1113
  • [9] Resistance mutations are rare among protease inhibitor treatment-naive hepatitis C genotype-1 patients with or without HIV coinfection
    Lisboa-Neto, Gaspar
    Noble, Caroline F.
    Rebello Pinho, Joao R.
    Malta, Fernanda M.
    Gomes-Gouvea, Michele S.
    Alvarado-Mora, Monica V.
    da Silva, Mariliza H.
    Leite, Andrea G. B.
    Piccoli, Leonora Z.
    Rodrigues, Flaviane K.
    Carrilho, Flair J.
    Mendes-Correa, Maria C.
    ANTIVIRAL THERAPY, 2015, 20 (03) : 281 - 287
  • [10] Amino acid substitutions in the Hepatitis C virus core region of genotype 1b in Moroccan patients
    Brahim, Ikram
    Ezzikouri, Sayeh
    Mtairag, El Mostafa
    Alaoui, Rhimou
    Nadir, Salwa
    Pineau, Pascal
    Benjelloun, Soumaya
    INFECTION GENETICS AND EVOLUTION, 2013, 14 : 102 - 104